Clotting and Anticoagulants

Who is a clotter? Who is a bleeder? Learn more about clotting and anticoagulation from hematologist Steven Fein, M.D.  

Target Audience

Family Medicine Physicians, Emergency Medicine Physicians, Hospitalists, Physician Assistants, Nurses, Nurse Practitioners and all other interested healthcare providers.

Learning Objectives

  • Prescribe a safe and effective plan for deep vein thrombosis (DVT) and pulmonary embolism (PE) prevention in hospitalized patients.
  • Explain to patients that the cause of DVT/PE is “clotting tendency.”
  • Prescribe novel oral anticoagulants (NOAC’s) to treat patients with DVT/PE.
  • Weigh presumed benefit against risk for long-term “maintenance” anticoagulants.
Additional information
Bibliography: 
  • Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., ... & Wang, S. (2009). Dabigatran versus warfarin in patients with atrial fibrillation. New England Journal of Medicine, 361(12), 1139-1151.
  • Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., ... & Becker, R. C. (2011). Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. New England Journal of Medicine, 365(10), 883-891.
  • Granger, C. B., Alexander, J. H., McMurray, J. J., Lopes, R. D., Hylek, E. M., Hanna, M., ... & Bahit, M. C. (2011). Apixaban versus warfarin in patients with atrial fibrillation. New England Journal of Medicine, 365(11), 981-992. 
Course summary
Available credit: 
  • 2.50 AMA PRA Category 1 Speaker Credit™
Course opens: 
05/01/2018
Course expires: 
05/01/2020
Rating: 
0

Steven Fein, M.D., MPH
Hematologist and Oncologist
Miami Cancer Institute
Baptist, South Miami, Homestead, Mariners, Doctors and West Kendall Baptist Hospitals

Steven Fein, M.D., MPH, has indicated that he is on the speakers bureaus for Jannsen Pharmaceuticals (Xarelto), Daichi-Sankyo (Injectafer), Pfizer/Bristol-Myers Squibb (Eliquis) and Amgen (Nplate). He will not include off-label or unapproved product usage in his presentation or discussion.

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose.

Disclosure Policy and Disclaimer

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
             
Baptist Health South Florida designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 2.50 AMA PRA Category 1 Speaker Credit™

Accreditation Period

Course opens: 
05/01/2018
Course expires: 
05/01/2020
Please login or register to take this course.

Required Hardware/software

This site is best viewed on the two most recent stable releases of the following browsers for all public pages:

PCs Running Windows

  • Google Chrome (Preferred): Download free web browser for PC, Mac, phone and tablet.
  • Internet Explorer (IE 11 and above recommended): You will be prompted to download videos before you are able to view. Click “download” to view video.  After a momentary pause, the recording will play.
  • Mozilla Firefox: You may be prompted under the “This Connection is Untrusted” screen to add “cmeonline.baptisthealth.net” and “cdn.baptisthealth.net” under “add exceptions”.

Apple Computers Running OSX

This site uses a responsive design, which allows the page layout of elements to change depending on the screen resolution. Certain functionality may change based on the screen resolution of smaller screens, such as the number of columns in a table.

Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to CME@BaptistHealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.